$148 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 35 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -5,000 | -100.0% | -0.02% | – |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -3,575 | -100.0% | -0.11% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -14,000 | -100.0% | -0.17% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.18% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PLC | $0 | – | -6,000 | -100.0% | -0.48% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -154,471 | -100.0% | -0.54% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -153,639 | -100.0% | -0.69% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS INC | $0 | – | -104,753 | -100.0% | -1.33% | – |
| Exit | CELLDEX THERAPEUTICS INCput | $0 | – | -1,000 | -100.0% | -2.65% | – | |
| Exit | IVERIC BIO INCcall | $0 | – | -1,500 | -100.0% | -2.69% | – | |
| SRPT | Exit | SAREPTA TEHRAPEUTICS INC | $0 | – | -32,770 | -100.0% | -3.33% | – |
| BLU | Exit | BELLUS HEALTH INC | $0 | – | -632,500 | -100.0% | -3.36% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -23,500 | -100.0% | -3.88% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.